BrotherlyACT for Youth Violence and Substance Use
(BrotherlyACT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a digital program called BrotherlyACT, designed to reduce youth violence and substance use among young Black males. The program includes educational modules, stress and mood management tools, and a chatbot for locating local services. Participants will either receive the program or be placed on a waitlist. It suits Black males aged 15 to 24 who have been hospitalized for an injury and can read English at a basic level. As an unphased trial, this study allows participants to contribute to innovative research aimed at improving community health.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the BrotherlyACT intervention is safe for young Black males?
Research has shown that the BrotherlyACT program, a digital tool for addressing youth violence and substance use, has undergone testing in earlier studies. These studies evaluated its safety and effectiveness for young people. Early results suggest that the program is generally easy to use, with participants reporting no major negative effects. The program includes learning modules, a safety planning toolkit, and a chatbot for support, all designed to reduce risks and provide help simply. Overall, evidence suggests that BrotherlyACT is a safe choice for those considering participation in this trial.12345
Why are researchers excited about this trial?
Researchers are excited about BrotherlyACT because it offers a fresh approach to tackling youth violence and substance use. Unlike standard treatments, which often involve lengthy counseling sessions, BrotherlyACT combines brief psychoeducational modules with a Safety Planning Toolkit and a Service Engagement Chatbot. This innovative use of technology provides personalized, on-demand support, including risk assessment and mood tracking, to help young people manage stress and set goals. By integrating mindfulness techniques and leveraging natural language processing for therapy, BrotherlyACT aims to engage youth in a more interactive and accessible way than traditional methods.
What evidence suggests that BrotherlyACT is effective for reducing youth violence and substance use?
Research shows that BrotherlyACT, which participants in this trial may receive, might help reduce violence and substance use among young people. Studies have found that similar technology-based programs can empower youth by teaching important life skills and reducing risky behaviors. BrotherlyACT combines technology with Acceptance and Commitment Therapy (ACT), which has improved mental health in other contexts. Early results from similar programs suggest they can help young people manage emotions and make safer choices. This digital program includes tools like mood tracking and stress reduction, specifically designed to support young Black males in challenging environments.23456
Who Is on the Research Team?
Chuka N Emezue, PhD, MPH
Principal Investigator
Rush University Medical Center
Are You a Good Fit for This Trial?
This trial is for young Black males who may be at risk of or affected by youth violence and substance use. It aims to help those in low-resource communities, particularly those who visit pediatric emergency services.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the BrotherlyACT digital intervention, including psychoeducational modules, a Safety Planning Toolkit, and a Service Engagement Chatbot
Follow-up
Participants are monitored for changes in youth violence, substance use, and psychological outcomes
What Are the Treatments Tested in This Trial?
Interventions
- BrotherlyACT
BrotherlyACT is already approved in United States for the following indications:
- Youth violence prevention
- Substance use prevention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rush University Medical Center
Lead Sponsor